Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To determine the analgesic dose-response characteristics of vapourized cannabinoids with
varying degrees of delta-9-tetrahydrocannabiol (THC)/ Cannabidiol (CBD) ratios.
Secondary Objectives:
- To compare functional changes and patient preferences of different cannabinoid (THC,
CBD) profiles in patients with OA (Osteoarthritis);
- To describe the Pharmacokinetics (PK) of vapourized cannabis of differing cannabinoid
profiles in patients with OA;
- To explore the short term safety of vapourized cannabis with different cannabinoid
profiles.
- To describe the incidence and severity of psychoactive events.
Phase:
Phase 2
Details
Lead Sponsor:
Prairie Plant Systems Inc.
Collaborators:
Algorithme Pharma Inc Dalhousie University McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre Research Institute of the McGill University Health Center